PETS — PetMed Express Income Statement
0.000.00%
Last trade - 00:00- $20.90m
- $7.82m
- $179.02m
Annual income statement for PetMed Express, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
R2022 March 31st | 2023 March 31st | C2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K/A | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 272 | 257 | 274 | 227 | 179 |
| Cost of Revenue | |||||
| Gross Profit | 76.9 | 70.7 | 84.8 | 69.1 | 52.3 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 248 | 251 | 282 | 229 | 238 |
| Operating Profit | 24.3 | 6.05 | -8.16 | -1.53 | -58.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 24.2 | 7.45 | -6.27 | -0.587 | -57.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 18.7 | 5.14 | -7.46 | -6.27 | -57.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 18.7 | 5.14 | -7.46 | -6.27 | -57.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 18.7 | 5.14 | -7.46 | -6.27 | -57.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.919 | 0.33 | -0.296 | -0.236 | -1.79 |
| Dividends per Share |